Bruker Corporation (BRKR) 23.68 $BRKR
Zacks.com featured highlights: DeVry Education Group, Herbalife, Children's Place, Bruker and Expeditors International of Washington
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:30AM CDT
Zacks.com featured highlights: DeVry Education Group, Herbalife, Children's Place, Bruker and Expeditors International of Washington
HLF: 61.04 (+0.91), PLCE: 82.10 (+1.10), EXPD: 49.92 (+0.66), BRKR: 23.68 (+0.24), DV: 19.97 (+0.62)
5 Liquid Stocks to Enhance Your Portfolio Return
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 7:00AM CDT
A strategy that successfully identifies efficient companies with favorable liquidity positions is poised to provide impressive returns irrespective of market conditions.
HLF: 61.04 (+0.91), PLCE: 82.10 (+1.10), EXPD: 49.92 (+0.66), BRKR: 23.68 (+0.24), DV: 19.97 (+0.62)
Research Report Initiated on Select Healthcare Equities
ACCESSWIRE - Fri Jul 01, 8:16AM CDT
LONDON, UK / ACCESSWIRE / July 1, 2016 / Active Wall ST announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Healthcare industry. Companies recently under review include Quintiles Transnational, Bruker, StemCells, and Hill-Rom. See our complete report on Quintiles Transnational at:
Q: 71.41 (+2.42), STEM: 0.40 (unch), BRKR: 23.68 (+0.24), HRC: 51.37 (+0.57)
5 Stocks to Buy on Stronger GDP Data
Swarup Gupta - Zacks Investment Research - Wed Jun 29, 9:34AM CDT
The most significant upward revisions which stand out are the extent of spending on software, research and development.
SNCR: 33.68 (+0.53), VRNS: 25.05 (+0.79), LH: 135.30 (+3.33), BRKR: 23.68 (+0.24), CRL: 85.52 (+1.02)
Bruker Poised on Product Launches amid Near-Term Risks
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 7:12AM CDT
On Jun 29, we issued an updated research report on Bruker Corporation (BRKR).
ICUI: 115.00 (+1.34), LMAT: 13.70 (+0.14), BRKR: 23.68 (+0.24), NUVA: 60.82 (+1.11)
Bruker Acquires Software Assets for Next-Generation Automated and Quantitative Mineral Identification and Characterization
PR Newswire - Mon Jun 20, 6:00AM CDT
Bruker today announced that it has acquired the assets of Yingsheng Technology Pty Ltd. in Brisbane, Australia, that relate to the 3rd generation Advanced Mineral Identification and Characterization System (AMICS) software package, and respective IP for advanced minerals identification and characterization.
BRKR: 23.68 (+0.24)
Bruker Collaborates with CDC to Advance Infectious Disease Surveillance
PR Newswire - Thu Jun 16, 6:00AM CDT
At the American Society for Microbiology (ASM) Microbe 2016 conference, Bruker today announces the results of a successful collaboration with the Special Bacteriology Reference Laboratory at the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia to create an expanded microorganism reference library for the Bruker MALDI Biotyper.
BRKR: 23.68 (+0.24)
Bruker Well Poised on Product Innovation amid Currency Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:23AM CDT
On Jun 14, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
ICUI: 115.00 (+1.34), LMAT: 13.70 (+0.14), BRKR: 23.68 (+0.24), NUVA: 60.82 (+1.11)
Short Interest In Bruker Expands By 15.4%
MarketNewsVideo.com - Fri Jun 10, 1:31PM CDT
The most recent short interest data has been released for the 05/31/2016 settlement date, which shows a 764,514 share increase in total short interest for Bruker Corp , to 5,717,406, an increase of 15.44% since 05/13/2016. Total short interest is...
BRKR: 23.68 (+0.24)
Bruker Shows Innovative rapifleX MALDI-TOF/TOF at ASMS 2016
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker introduces rapifleX(TM), the highest performance MALDI-TOF/TOF mass spectrometer, which had been shown as work-in-progress to early adopters at HUPO 2015. The rapifleX is by far the most advanced TOF/TOF system today, and was re-designed from the ground up to meet today's highest demands for in-depth intact and top-down protein characterization, and high-performance, high-throughput mass spectrometry imaging (MSI).
BRKR: 23.68 (+0.24)
Bruker Launches rapifleX MALDI PharmaPulse Solution for uHTS
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX(TM) MALDI PharmaPulse(TM) (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
BRKR: 23.68 (+0.24)
Bruker Introduces Innovative timsTOF(TM) Mass Spectrometer
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker introduces an entirely new mass spectrometry technology platform: the innovative timsTOF(TM) system combines very high ion mobility resolution greater than 200, using Bruker's proprietary Trapped Ion Mobility Spectrometry (TIMS), with Bruker's ultra-high performance ESI-QTOF mass spectrometry.
BRKR: 23.68 (+0.24)
Why These Stocks are Under the Investor Community's Microscope? - Bruker, Quintiles Transnational Holdings, iKang Healthcare Group, and TrovaGene
PR Newswire - Wed Jun 01, 7:20AM CDT
In today's pre-market research, ActiveWallSt.com has selected the following Medical Laboratories and Research stocks for your evaluation: Bruker Corp. (NASDAQ: BRKR), Quintiles Transnational Holdings Inc. (NYSE: Q), iKang Healthcare Group Inc. (NASDAQ: KANG), and TrovaGene Inc. (NASDAQ: TROV). Access these equities free technical alerts at:
Q: 71.41 (+2.42), TROV: 5.11 (+0.30), KANG: 18.20 (+0.26), BRKR: 23.68 (+0.24)
Dr. Cynthia Friend Joins Bruker Board of Directors
PR Newswire - Mon May 23, 9:46AM CDT
Bruker Corporation (NASDAQ: BRKR) today announced that its shareholders have elected Dr. Cynthia Friend as a new member of the Board of Directors, effective May 20, 2016.
BRKR: 23.68 (+0.24)
Waters Corp. Expands Xevo Line with Xevo TQ-XS Launch
Zacks Equity Research - Zacks Investment Research - Tue May 17, 8:44AM CDT
Waters Corporation (WAT) expanded its portfolio of Xevo mass spectrometers with the launch of Xevo TQ-XS mass spectrometer, which is arguably the most sensitive instrument of its kind in the market.
BEAT: 16.54 (+0.17), BRKR: 23.68 (+0.24), PKI: 53.95 (+1.36), WAT: 146.53 (+4.06)
Bruker: Q1 Results Strong, Product Launches Hold Promise
Zacks Equity Research - Zacks Investment Research - Tue May 17, 7:02AM CDT
Bruker (BRKR) started 2016 on a promising note, with its first-quarter results beating the Zacks Consensus Estimate on both the fronts.
BSX: 23.90 (+0.24), SRDX: 24.66 (+0.76), BAX: 46.65 (+0.53), BRKR: 23.68 (+0.24)
Bruker Announces Quarterly Dividend
PR Newswire - Tue May 17, 6:33AM CDT
Bruker Corporation (NASDAQ: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company's common stock. The dividend will be paid on June 24, 2016 to stockholders of record as of June 6, 2016.
BRKR: 23.68 (+0.24)
Bruker Introduces New High-Value Analytical Solutions and High Performance Scientific Instruments for Applied and Industrial Markets at Analytica 2016
PR Newswire - Tue May 10, 3:25AM CDT
This week at Analytica 2016, Bruker (NASDAQ: BRKR) is showcasing new products and analytical solutions for improved performance and customer experience in pharmaceutical, industrial and applied markets. Designed to increase sensitivity, improve specificity and maximize productivity, the new Bruker products introduced at Analytica 2016 include:
BRKR: 23.68 (+0.24)
PerkinElmer (PKI) Beats Q1 Earnings & Revenues, View Up
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:27AM CDT
PerkinElmer Inc (PKI) reported first-quarter 2016 earnings of 56 cents per share, which beat the Zacks Consensus Estimate by a nickel.
BRKR: 23.68 (+0.24), PKI: 53.95 (+1.36), WAT: 146.53 (+4.06), MTD: 373.03 (+6.28)
Downgrade Alert for Bruker (BRKR)
Comtex SmarTrend(R) - Fri May 06, 3:12AM CDT
Bruker (NASDAQ:BRKR) was downgraded from Buy to Neutral at BTIG today. The stock closed yesterday at $27.20 on volume of 1.9 million shares, above average daily volume of 1.1 million. Over the past year, Bruker has traded in a range of $15.78 to $29.85 and closed yesterday at $27.20, 72% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.7% while the 200-day MA has risen 0.6%.
BRKR: 23.68 (+0.24)
Zacks.com featured highlights: DeVry Education Group, Herbalife, Children's Place, Bruker and Expeditors International of Washington
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:30AM CDT
Zacks.com featured highlights: DeVry Education Group, Herbalife, Children's Place, Bruker and Expeditors International of Washington
HLF: 61.04 (+0.91), PLCE: 82.10 (+1.10), EXPD: 49.92 (+0.66), BRKR: 23.68 (+0.24), DV: 19.97 (+0.62)
5 Liquid Stocks to Enhance Your Portfolio Return
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 7:00AM CDT
A strategy that successfully identifies efficient companies with favorable liquidity positions is poised to provide impressive returns irrespective of market conditions.
HLF: 61.04 (+0.91), PLCE: 82.10 (+1.10), EXPD: 49.92 (+0.66), BRKR: 23.68 (+0.24), DV: 19.97 (+0.62)
Research Report Initiated on Select Healthcare Equities
ACCESSWIRE - Fri Jul 01, 8:16AM CDT
LONDON, UK / ACCESSWIRE / July 1, 2016 / Active Wall ST announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Healthcare industry. Companies recently under review include Quintiles Transnational, Bruker, StemCells, and Hill-Rom. See our complete report on Quintiles Transnational at:
Q: 71.41 (+2.42), STEM: 0.40 (unch), BRKR: 23.68 (+0.24), HRC: 51.37 (+0.57)
5 Stocks to Buy on Stronger GDP Data
Swarup Gupta - Zacks Investment Research - Wed Jun 29, 9:34AM CDT
The most significant upward revisions which stand out are the extent of spending on software, research and development.
SNCR: 33.68 (+0.53), VRNS: 25.05 (+0.79), LH: 135.30 (+3.33), BRKR: 23.68 (+0.24), CRL: 85.52 (+1.02)
Bruker Poised on Product Launches amid Near-Term Risks
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 7:12AM CDT
On Jun 29, we issued an updated research report on Bruker Corporation (BRKR).
ICUI: 115.00 (+1.34), LMAT: 13.70 (+0.14), BRKR: 23.68 (+0.24), NUVA: 60.82 (+1.11)
Bruker Acquires Software Assets for Next-Generation Automated and Quantitative Mineral Identification and Characterization
PR Newswire - Mon Jun 20, 6:00AM CDT
Bruker today announced that it has acquired the assets of Yingsheng Technology Pty Ltd. in Brisbane, Australia, that relate to the 3rd generation Advanced Mineral Identification and Characterization System (AMICS) software package, and respective IP for advanced minerals identification and characterization.
BRKR: 23.68 (+0.24)
Bruker Collaborates with CDC to Advance Infectious Disease Surveillance
PR Newswire - Thu Jun 16, 6:00AM CDT
At the American Society for Microbiology (ASM) Microbe 2016 conference, Bruker today announces the results of a successful collaboration with the Special Bacteriology Reference Laboratory at the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia to create an expanded microorganism reference library for the Bruker MALDI Biotyper.
BRKR: 23.68 (+0.24)
Bruker Well Poised on Product Innovation amid Currency Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:23AM CDT
On Jun 14, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
ICUI: 115.00 (+1.34), LMAT: 13.70 (+0.14), BRKR: 23.68 (+0.24), NUVA: 60.82 (+1.11)
Short Interest In Bruker Expands By 15.4%
MarketNewsVideo.com - Fri Jun 10, 1:31PM CDT
The most recent short interest data has been released for the 05/31/2016 settlement date, which shows a 764,514 share increase in total short interest for Bruker Corp , to 5,717,406, an increase of 15.44% since 05/13/2016. Total short interest is...
BRKR: 23.68 (+0.24)
Bruker Shows Innovative rapifleX MALDI-TOF/TOF at ASMS 2016
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker introduces rapifleX(TM), the highest performance MALDI-TOF/TOF mass spectrometer, which had been shown as work-in-progress to early adopters at HUPO 2015. The rapifleX is by far the most advanced TOF/TOF system today, and was re-designed from the ground up to meet today's highest demands for in-depth intact and top-down protein characterization, and high-performance, high-throughput mass spectrometry imaging (MSI).
BRKR: 23.68 (+0.24)
Bruker Launches rapifleX MALDI PharmaPulse Solution for uHTS
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX(TM) MALDI PharmaPulse(TM) (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
BRKR: 23.68 (+0.24)
Bruker Introduces Innovative timsTOF(TM) Mass Spectrometer
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker introduces an entirely new mass spectrometry technology platform: the innovative timsTOF(TM) system combines very high ion mobility resolution greater than 200, using Bruker's proprietary Trapped Ion Mobility Spectrometry (TIMS), with Bruker's ultra-high performance ESI-QTOF mass spectrometry.
BRKR: 23.68 (+0.24)
Why These Stocks are Under the Investor Community's Microscope? - Bruker, Quintiles Transnational Holdings, iKang Healthcare Group, and TrovaGene
PR Newswire - Wed Jun 01, 7:20AM CDT
In today's pre-market research, ActiveWallSt.com has selected the following Medical Laboratories and Research stocks for your evaluation: Bruker Corp. (NASDAQ: BRKR), Quintiles Transnational Holdings Inc. (NYSE: Q), iKang Healthcare Group Inc. (NASDAQ: KANG), and TrovaGene Inc. (NASDAQ: TROV). Access these equities free technical alerts at:
Q: 71.41 (+2.42), TROV: 5.11 (+0.30), KANG: 18.20 (+0.26), BRKR: 23.68 (+0.24)
Dr. Cynthia Friend Joins Bruker Board of Directors
PR Newswire - Mon May 23, 9:46AM CDT
Bruker Corporation (NASDAQ: BRKR) today announced that its shareholders have elected Dr. Cynthia Friend as a new member of the Board of Directors, effective May 20, 2016.
BRKR: 23.68 (+0.24)
Waters Corp. Expands Xevo Line with Xevo TQ-XS Launch
Zacks Equity Research - Zacks Investment Research - Tue May 17, 8:44AM CDT
Waters Corporation (WAT) expanded its portfolio of Xevo mass spectrometers with the launch of Xevo TQ-XS mass spectrometer, which is arguably the most sensitive instrument of its kind in the market.
BEAT: 16.54 (+0.17), BRKR: 23.68 (+0.24), PKI: 53.95 (+1.36), WAT: 146.53 (+4.06)
Bruker: Q1 Results Strong, Product Launches Hold Promise
Zacks Equity Research - Zacks Investment Research - Tue May 17, 7:02AM CDT
Bruker (BRKR) started 2016 on a promising note, with its first-quarter results beating the Zacks Consensus Estimate on both the fronts.
BSX: 23.90 (+0.24), SRDX: 24.66 (+0.76), BAX: 46.65 (+0.53), BRKR: 23.68 (+0.24)
Bruker Announces Quarterly Dividend
PR Newswire - Tue May 17, 6:33AM CDT
Bruker Corporation (NASDAQ: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company's common stock. The dividend will be paid on June 24, 2016 to stockholders of record as of June 6, 2016.
BRKR: 23.68 (+0.24)
Bruker Introduces New High-Value Analytical Solutions and High Performance Scientific Instruments for Applied and Industrial Markets at Analytica 2016
PR Newswire - Tue May 10, 3:25AM CDT
This week at Analytica 2016, Bruker (NASDAQ: BRKR) is showcasing new products and analytical solutions for improved performance and customer experience in pharmaceutical, industrial and applied markets. Designed to increase sensitivity, improve specificity and maximize productivity, the new Bruker products introduced at Analytica 2016 include:
BRKR: 23.68 (+0.24)
PerkinElmer (PKI) Beats Q1 Earnings & Revenues, View Up
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:27AM CDT
PerkinElmer Inc (PKI) reported first-quarter 2016 earnings of 56 cents per share, which beat the Zacks Consensus Estimate by a nickel.
BRKR: 23.68 (+0.24), PKI: 53.95 (+1.36), WAT: 146.53 (+4.06), MTD: 373.03 (+6.28)
Downgrade Alert for Bruker (BRKR)
Comtex SmarTrend(R) - Fri May 06, 3:12AM CDT
Bruker (NASDAQ:BRKR) was downgraded from Buy to Neutral at BTIG today. The stock closed yesterday at $27.20 on volume of 1.9 million shares, above average daily volume of 1.1 million. Over the past year, Bruker has traded in a range of $15.78 to $29.85 and closed yesterday at $27.20, 72% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.7% while the 200-day MA has risen 0.6%.
BRKR: 23.68 (+0.24)
